BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease Study

Reuters11-18

Annovis Bio Inc ANVS.N:

ANNOVIS ANNOUNCES FDA MEETING TO DISCUSS PARKINSON'S DISEASE DEMENTIA PROGRAM; REAFFIRMS FDA ALIGNMENT ON PIVOTAL PHASE 3 ALZHEIMER'S DISEASE STUDY
ANNOVIS BIO INC - ANNOUNCES FDA TYPE C MEETING FOR JANUARY 2026

Source text: ID:nGNX9kxr7c

Further company coverage: ANVS.N

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2584519930?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-18 21:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2584519930","market":"nz","top_or_hot":-1,"title":"BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease Study","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease Study</title></head><body><p><a href=\"https://laohu8.com/S/ANVS\">Annovis Bio</a> Inc <span>ANVS.N</span>:</p><ul><li><p>ANNOVIS ANNOUNCES FDA MEETING TO DISCUSS PARKINSON'S DISEASE DEMENTIA PROGRAM; REAFFIRMS FDA ALIGNMENT ON PIVOTAL PHASE 3 ALZHEIMER'S DISEASE STUDY</p></li><li><p>ANNOVIS BIO INC - ANNOUNCES FDA TYPE C MEETING FOR JANUARY 2026</p></li></ul><p>Source text: <span>ID:nGNX9kxr7c</span></p><p>Further company coverage: <span>ANVS.N</span></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease Study</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease Study\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-18 21:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease Study</title></head><body><p><a href=\"https://laohu8.com/S/ANVS\">Annovis Bio</a> Inc <span>ANVS.N</span>:</p><ul><li><p>ANNOVIS ANNOUNCES FDA MEETING TO DISCUSS PARKINSON'S DISEASE DEMENTIA PROGRAM; REAFFIRMS FDA ALIGNMENT ON PIVOTAL PHASE 3 ALZHEIMER'S DISEASE STUDY</p></li><li><p>ANNOVIS BIO INC - ANNOUNCES FDA TYPE C MEETING FOR JANUARY 2026</p></li></ul><p>Source text: <span>ID:nGNX9kxr7c</span></p><p>Further company coverage: <span>ANVS.N</span></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nTUA9LWBT3:1","article_id":"2584519930","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2584519930","pubTimestamp":1763471865,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease StudyAnnovis Bio Inc ANVS.N:ANNOVIS ANNOUNCES FDA MEE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ANVS":"Annovis Bio, Inc."},"translate_title":"简介-Annovis宣布召开FDA会议讨论帕金森病痴呆计划重申FDA与关键3期阿尔茨海默病研究的一致性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ANVS":0.9},"content_text":"BRIEF-Annovis Announces FDA Meeting To Discuss Parkinson's Disease Dementia Program Reaffirms FDA Alignment On Pivotal Phase 3 Alzheimer's Disease StudyAnnovis Bio Inc ANVS.N:ANNOVIS ANNOUNCES FDA MEETING TO DISCUSS PARKINSON'S DISEASE DEMENTIA PROGRAM; REAFFIRMS FDA ALIGNMENT ON PIVOTAL PHASE 3 ALZHEIMER'S DISEASE STUDYANNOVIS BIO INC - ANNOUNCES FDA TYPE C MEETING FOR JANUARY 2026Source text: ID:nGNX9kxr7cFurther company coverage: ANVS.N","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2584519930","isCrawlerRequest":true}